INVITRO AND INVIVO EFFECT OF PC-904, A NEW BROAD-SPECTRUM PENICILLIN, ON OCULAR STRAINS OF PSEUDOMONAS-AERUGINOSA

被引：0

作者：

OKUMOTO, M ^{[1
]}

SMOLIN, G ^{[1
]}

OHNO, S ^{[1
]}

DYLIACCO, J ^{[1
]}

MINTSIOULIS, G ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT OPHTHALMOL,SAN FRANCISCO,CA 94143

来源：

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE | 1978年 / 13卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：200 / 205

页数：6

共 40 条

[31] PREDICTION OF PIPERACILLIN TAZOBACTAM SUSCEPTIBILITY AMONG ENTEROBACTERIACEAE, PSEUDOMONAS-AERUGINOSA, AND OTHER BACTERIA USING TICARCILLIN-CLAVULANIC ACID, CEFTAZIDIME, AND OTHER BROAD-SPECTRUM ANTIMICROBIAL IN-VITRO TEST-RESULTS
JONES, RN
SUTTON, LD
CANTRELL, HF
LANKFORD, RB
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 20 (03) : 143 - 149
[32] Overly broad-spectrum antibiotic treatment of wild-type Pseudomonas aeruginosa infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort study
Ourghanlian, Clement
Fihman, Vincent
Morel, Antoine
Lafont, Charlotte
Galy, Adrien
Calimouttoupoulle, Eimma
Woerther, Paul-Louis
Lepeule, Raphael
JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (05):
[33] Identification of a novel broad-spectrum anti-fungal strain of Pseudomonas aeruginosa (SU8) and effect of its crude metabolites against Rhizoctonia solani and Pyricularia oryzae
Zhang, Y.
Su, P.
Wang, C.
Liao, X.
EGYPTIAN JOURNAL OF BIOLOGICAL PEST CONTROL, 2015, 25 (02) : 295 - 304
[34] PA-I AND PA-II LECTIN INTERACTIONS WITH THE ABO(H)-BLOOD AND P-BLOOD GROUP GLYCOSPHINGOLIPID ANTIGENS MAY CONTRIBUTE TO THE BROAD-SPECTRUM ADHERENCE OF PSEUDOMONAS-AERUGINOSA TO HUMAN TISSUES IN SECONDARY INFECTIONS
GILBOAGARBER, N
SUDAKEVITZ, D
SHEFFI, M
SELA, R
LEVENE, C
GLYCOCONJUGATE JOURNAL, 1994, 11 (05) : 414 - 417
[35] L-658,310, A NEW INJECTABLE CEPHALOSPORIN .2. INVITRO AND INVIVO INTERACTIONS BETWEEN L-658,310 AND VARIOUS AMINOGLYCOSIDES OR CIPROFLOXACIN VERSUS CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA
VALIANT, ME
GILFILLAN, EC
GADEBUSCH, HH
PELAK, BA
JOURNAL OF ANTIBIOTICS, 1989, 42 (05): : 807 - 814
[36] Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY antimicrobial surveillance program, 1997-1998
Ramphal, R
Hoban, DJ
Pfaller, MA
Jones, RN
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (02) : 125 - 129
[37] New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.: Part 2:: Synthesis and structure-activity relationships in the S-3578 series
Yoshizawa, H
Kubota, T
Itani, H
Ishitobi, H
Miwa, H
Nishitani, Y
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (15) : 4211 - 4219
[38] Effect of modification of penicillin-binding protein 3 on susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam, and cefiderocol of Escherichia coli strains producing broad-spectrum β-lactamases
Le Terrier, Christophe
Nordmann, Patrice
Buchs, Chloe
Poirel, Laurent
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (04)
[39] 6R-[(R)-2-[3-[2-(P-AMINOSULFONYL)ANILINO-4-HYDROXY-5-PYRIMIDINYL]UREIDO]-2-(4-HYDROXYPHENYL)ACETAMIDO]-PENICILLANIC ACID, SODIUM-SALT (VX-VC 43), A NEW BROAD-SPECTRUM BETA-LACTAM ANTIBIOTIC - ANTIBIOTIC-ACTIVITY INVITRO AND INVIVO
LECHNER, U
APPEL, KR
WERNER, RG
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35 (1A): : 351 - 355
[40] New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa.: Part 3:: 7β-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureidol-1-pyridinium at C-3′
Yoshizawa, H
Kubota, T
Itani, H
Minami, K
Miwa, H
Nishitani, Y
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (15) : 4221 - 4231

← 1 2 3 4 →